Effect and safety of the treatment were assessed , including fatality , liver functions [ total bilirubin ( TBIL ) , albumin ( ALB ) , alanine aminotransferase ( ALT ) , and aspartate transaminase ( AST ) ] , and prothrombin activity ( PTA ) after treatment and at week 48 of follow-ups .